FDA Okays Drug for Frequent Nocturia
By medpagetoday.com
For the first time the FDA approved a treatment for frequent nighttime urination due to overproduction of urine.
The drug, desmopressin acetate (Noctiva), is delivered as a nasal spray and is approved for use only in adults who awaken two or more times nightly to urinate due to nocturnal polyuria. Used daily "approximately 30 minutes before going to bed, it works by increasing the absorption of water through the kidneys, which leads to less urine production," the agency said.
In a statement, Hylton V. Joffe, MD, MMSc, of the FDA's Center for Drug Evaluation and Research, said, "It is important to know that Noctiva is not approved for all causes of nighttime urination, so patients should discuss their symptoms with their healthcare provider who can determine the underlying cause of the nighttime urination and whether Noctiva is right for them."
The FDA cautioned that nocturia can be caused by a wide variety of conditions, "such as congestive heart failure, poorly controlled diabetes mellitus, medications, or diseases of the bladder or prostate. Before considering Noctiva, healthcare providers should evaluate each patient for possible causes for the nocturia, and optimize the treatment of underlying conditions that may be contributing to the nighttime urination. Because Noctiva is approved only for adults with nocturia caused by nocturnal polyuria, healthcare providers should confirm overproduction of urine at night with a 24-hour urine collection, if one has not been obtained previously."
Moreover, the FDA warned that underlying conditions, including congestive heart failure, could make use of the drug unsafe.
Noctiva is taken daily, approximately 30 minutes before going to bed. It works by increasing the absorption of water through the kidneys, which leads to less urine production.
The approval was based on two 12-week, randomized, placebo-controlled trials in 1,045 patients 50 years of age and older with nocturia due to nocturnal polyuria. Both studies demonstrated only a small benefit compared with placebo, but "more patients treated with Noctiva were able to at least halve their number of nighttime urinations, and patients treated with Noctiva had more nights with one or fewer night-time urinations."
The drug will carry a boxed warning that it can cause hyponatremia, which can be life-threatening if severe.
"Noctiva should not be used in patients at increased risk of severe hyponatremia, such as those with excessive fluid intake, those who have illnesses that can cause fluid or electrolyte imbalances, certain patients with kidney damage, and in those using certain medicines, known as loop diuretics or glucocorticoids," the FDA said. The drug should not be used in pregnant women or children.
Side effects included nasal discomfort, nasal congestion, sneezing, hypertension, nose bleeds, bronchitis, and dizziness.
Noctiva is marketed by Milford, Pennsylvania-based Renaissance Lakewood, LLC for Serenity Pharmaceuticals, LLC.
Source: http://www.medpagetoday.com/urology/urology/63578
Thursday, May 28, 2026
Getting a Prescription Online Safely
The ability to obtain a prescription through an online telehealth consultation has made healthcare more accessible for millions of patients. Getting a prescription online can save time, reduce clinic visits for manageable conditions, and improve access for patients with mobility issues or those in underserved areas. However, it is important to understand how to do this safely and to recognize the difference between legitimate services and unsafe alternatives. A safe online prescription process begins with a genuine medical evaluation by a licensed healthcare provider. Reputable telehealth platforms require patients to complete a detailed health history form and participate in either a live video consultation or an asynchronous review of their information by a licensed physician or nurse practitioner. The provider uses this information to make a clinical determination about whether a prescription is appropriate. No legitimate provider will issue a prescription without this evaluation step. Once a prescription is written, it is sent electronically to a pharmacy chosen by the patient. Most telehealth platforms can send prescriptions to national pharmacy chains as well as local independent pharmacies. Some platforms partner with mail-order pharmacies that deliver medications directly to the patient's home. For antibiotic prescriptions, patients can access services through trusted platforms like https://www.amoxilcompharm.com/ that combine licensed provider consultations with convenient pharmacy fulfillment. There are clear warning signs that an online prescription service may not be legitimate. These include websites that offer to sell prescription medications without any consultation, sites that ask only for payment and a self-reported symptom checklist with no provider review, and platforms that ship controlled substances or antibiotics with no clinical evaluation. Buying prescription medications from such sources is illegal, unsafe, and potentially harmful. Counterfeit or substandard medications purchased from unregulated websites can cause serious health harm. Patients should verify that any telehealth platform they use is compliant with privacy regulations such as HIPAA in the United States, employs licensed providers, and requires a real consultation before prescribing. Checking reviews, verifying provider credentials, and confirming that the pharmacy is licensed and accredited are all wise steps. For educational information on safe online prescribing practices and antibiotic access, visit https://amoxicillina.online/ for trustworthy patient health resources.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.